RMRonald Mbiine

Ronald Mbiine

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ronald Mbiine has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Epidemiology of keloids among university students in Uganda

    by Ronald Mbiine, Misaki Wayengera, Noah Kiwanuka, Ian Munabi, Haruna Muwonge, Cephas Nakanwagi, Moses Joloba, Moses Galukande

    Keloids are benign yet persistent fibroproliferative disorders characterized by raised, irregular scars that extend beyond the original wound margins. In addition to causing disfiguring scars, pain, and restricted mobility, keloids significantly impact psychosocial well-being, often leading to emotional distress and socioeconomic challenges for the affected individuals. Although keloids are recognized as being most prevalent among individuals of African descent, there remains a paucity of epidemiological data on their prevalence in African populations. This gap in knowledge has contributed to the limited prioritization of keloid management in healthcare policies and treatment strategies. This study aimed to determine the prevalence of keloids among university students in Uganda and analyze the demographic and patient-related factors associated with keloid development, with particular focus on age, sex, ethnicity, family history, blood group, and skin complexion. A descriptive, cross-sectional study was conducted among 502 university students at Makerere University in Kampala, Uganda. Data were collected using structured questionnaires and direct visual inspection of scars by trained research assistants. Statistical analyses were performed to determine the prevalence and evaluate the associations between keloids and participant characteristics. The prevalence of keloids among study participants was 4.18%, while hypertrophic scars were observed in 20.32%. A positive family history was identified as the strongest association with keloid development. No significant associations were found between keloid formation and ethnicity, blood group, or skin complexion. The study provides population-based prevalence data on keloids and emphasizes the role of genetic predisposition in keloid formation. The findings underscore the need for increased awareness, identification of at-risk populations, and strategized preventive interventions for keloid development.

  • Open Access

    Description of clinical and histopathological characteristics of keloids in a sub-Saharan African population

    by Ronald Mbiine, Misaki Wayengera, Noah Kiwanuka, Ian G Munabi, Haruna Muwonge, Cephas Nakanwagi, Biratu Olika, Lekuya Herve Monka, Moses Joloba, Moses Galukande

    Background: Keloids are among the leading benign skin conditions globally, affecting up to 16% of the African population. They are characterized by aggressive behaviour, high recurrence rates and poor treatment outcomes, particularly in African populations. Despite this, most information on keloids in sub-Saharan Africa remains anecdotal, with limited comprehensive studies describing their clinical and pathological characteristics. Objectives: To analyse the clinical and histopathological features of keloids in a sub-Saharan African population. Methods: Following ethical approval, 231 participants were enrolled in a cross-sectional study conducted at the 2 national referral plastic surgical centres in Uganda. Data on demographics, clinical presentations and histopathological features of keloids were collected and analysed. Results: Sixty-four per cent of participants (n = 148/231) were women, 63.3% (n = 133/210) resided in central Uganda and 82.3% (n = 190/231) belonged to the Bantu ethnic group, with those belonging to the Baganda tribe predominating (n = 97/231; 42.0%). Keloids were broadly classified into sessile (n = 116/231; 50.2%) and nodular types. The most frequently affected anatomical sites were the head and neck (n = 106/231; 45.9%) and the trunk (n = 52/231; 22.5%). Additionally, 58.0% (n = 134/231) of participants had multiple keloids. Histopathological analysis of 35 excised specimens revealed that keloids are primarily a dermal disease, characterized by excessive collagen deposition, particularly hyalinized collagen. Conclusions: Keloids in African populations exhibit a slight female predominance, a tendency toward multiplicity and larger lesion volumes. Histopathological findings highlight excessive collagen deposition as a hallmark, emphasizing the need for tailored approaches to improve treatment outcomes.


  • Open Access

    Effect of perioperative blood transfusion on complications following emergency non-trauma laparotomy in Mulago hospital: A prospective cohort study.

    by Flavius Ebaisem Egbe, Ronald Mbiine, Michael Okello, Richard Newton Iranya, Paul Okeny

    Background: Blood transfusion may be required in the management of patients undergoing emergency non-trauma laparotomy. However, several retrospective cohort studies involving patients undergoing laparotomy for benign and malignant indications have identified blood transfusion as a significant predictor of postoperative infections and mortality. Still, no study has explored such an association in our setting. We aimed to determine the effect of perioperative blood transfusion on the 30-day risk of surgical site infections and mortality among patients undergoing emergency non-trauma laparotomy in a large urban tertiary hospital in a low-resource setting. Methods: In this prospective cohort study, we recruited 160 consecutive adult patients admitted to the general surgery wards 48 hours after emergency non-trauma laparotomy. We grouped them based on transfusion exposure status. Independent variables, including perioperative blood transfusion and confounders, were recorded on entry, while dependent variables, including the presence or absence of surgical site infection and mortality, were obtained over a 30-day follow-up period. The data were analysed using EPI INFO version 7, SPSS version 29, and Stata version 14; pResults: All 160 participants recruited, 28 (17.5%) transfused (exposed) and 132 (82.5%) not transfused (non-exposed), were included in the final analysis. Transfusion exposure (RR, 7.81; 95% CI, 2.58 – 23.63; p=0.0003) and preoperative leucocytosis/leukopenia (RR, 2.19; 95% CI, 1.04 – 4.65; p=0.040) were identified as independent risk factors for SSI after multivariate logistic regression analysis adjusted for confounders including preoperative anaemia, young-to-middle-aged adults, cloudy/purulent/feculent exudate, gut perforation diagnosis, female sex, and registrar-led surgical team. Furthermore, transfusion exposure (HR, 3.36; 95% CI, 1.11 – 10.25; p=0.033) and old age ≥60 years (HR, 5.50; 95% CI, 1.67 – 18.11; p=0.005) were identified as independent risk factors for 30-day mortality after multivariate Cox regression analysis adjusted for confounders including high ASA score, immunodeficiency, cloudy/purulent/feculent exudate, bowel obstruction and high-risk procedure for bowel leak. Conclusion: Among patients undergoing emergency non-trauma laparotomy, perioperative blood transfusion compared with no perioperative blood transfusion increased the 30-day risk of SSI by 7.81 and the 30-day mortality risk by 3.36. A restrictive transfusion strategy and a more extensive multicentre prospective cohort study are recommended.


    • 15 December 2023
      • Vol. 12  (5) , 98-111

    Autologous adipose-derived stromal vascular fraction (SVF) in scar treatment among patients with keloids and hypertrophic scars: a systematic review and meta-analysis of current practices and outcomes.

    by Ronald Mbiine, Misaki Wayengera, Noah Kiwanuka, Ian Munabi, Haruna Muwonge, Cephas Nakanwagi, Moses Joloba, Moses Galukande

    Keloids and hypertrophic scars are some of the most common skin conditions globally, associated with poor treatment response and high recurrence rates. Autologous adipose-derived stromal vascular fraction (SVF) is increasingly recognized as an emerging therapy albeit limited literature on its outcome in scar treatment. This review aimed to describe the current practices and outcomes of adipose-derived stromal Vascular Fraction in scar treatment. This systematic review assessed articles describing the use of SVF in scar treatment published between 2000 and 2023. Article searches of Medline/PubMed, Cochrane Library, and Embase databases using Mesh terms and the Boolean operators ("AND", "OR") by two independent researchers were done whilst following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Clinical studies assessing SVF in scar treatment with a primary outcome measure being an improvement in scar characteristics including the thickness, scar assessment scores were included. Among the 1425 studies identified in the search, 20 studies met the inclusion criteria with a total of 493 patients included. Eight of these were clinical trials with the rest being observational studies. Follow-up ranged from 3 months to 24 months. In all studies, there was an improvement in scar characteristics following single-dose treatment with SVF or its equivalent. All studies reported SVF to be safe. The review found that autologous adipose-derived SVF is a clinically effective therapy for keloids and scar treatment.


    • 1 January 2023
      • Vol. 12  (2) , 23-36

    Safety and feasibility of autologous adipose-derived stromal vascular fraction in the treatment of keloids: a phase one randomized controlled pilot trial

    by Ronald Mbiine, Anthony Kayiira, Misaki Wayengera, Munabi Ian Guyton, Noah Kiwanuka, Rose Alenyo, Edris Wamala Kalanzi, Haruna Muwonge, Cephas Nakanwagi, Moses Joloba, et al.

    Introduction: Autologous adipose-derived stromal vascular fraction (SVF) has been described to have therapeutic benefits in the treatment of keloids. However, most of the evidence on its efficacy is based on observational studies the majority of which are conducted in high-income countries and yet the highest burden of keloids is in low- and middle-income countries (LMICs). Objectives: We set out to determine the safety and feasibility of using autologous adipose derived stromal vascular fraction in the treatment of keloids in LMICs. Methods: In this phase II randomized controlled pilot clinical trial conducted in the Plastic Surgery Unit of Kirruddu National Referral Hospital in Kampala Uganda, 8 patients were assigned a 1:1 ratio to either SVF or triamcinolone acetonide (TAC) arms. In the SVF arm, a median (Inter quartile range) amount of stromal cell infiltration of 2.7x10(6) (11x10(6)) was administered, while the controls received 10 mg/ml TAC at a ratio of 1:1 TAC to keloid volume. Primary endpoints were adverse event development based on the Common Terminology Criteria for Adverse Events (CTCAE) v5.0 tool and feasibility assessment based on >= 70% recruitment feasibility and >= 80% interventional feasibility rates. Results: The participants' mean age was 27.9 (+/- 6.5) years, with a female predilection of 5 (63%). Overall, no adverse events were reported in the SVF arm, while ulceration in a single patient in the TAC arm, which was a grade II adverse event, was reported. Recruitment feasibility of 80% and interventional feasibility with 100% completion were reported. Conclusion: Based on our findings, an autologous adipose-derived stromal vascular fraction is feasible and safe for the treatment of keloids in LMICs.


    • 19 August 2022
      • Vol. 11  (4) , 56-+

    Adipose-derived stromal vascular fraction (SVF) in scar treatment: a systematic review protocol

    by Ronald Mbiine, Misaki Wayengera, Moses Ocan, Noah Kiwanuka, Ian Munabi, Haruna Muwonge, Herve Monka Lekuya, Ismael Kawooya, Cephas Nakanwagi, Alison Annet Kinengyere, et al.

    Background: Autologous adipose-derived stromal vascular fraction (SVF) is an emerging therapy that is being pioneered as a potential treatment for keloids and hypertrophic scars. Up to this point, there isn't a cure for keloids and hypertrophic scars yet they comprise the commonest benign skin disorders. Despite published studies reporting potential therapeutic benefits of SVF, their use and efficacy on scar improvement are not clearly described. The aim of this review is to describe the clinical practice involved in harvesting, processing, utilization of SVF, and associated efficacy in scar treatment. Methods: We shall include published clinical articles evaluating the efficacy of SVF on improving scar characteristics and assessment scores among adults with keloids or hypertrophic scars. Article search of Medline/PubMed, Cochrane Library and Embase using Mesh terms of "scars " and "stromal vascular fraction " combined with the Boolean operators ( "AND ", "OR ") will be performed by two independent researchers following the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) statement. The primary outcome measure will be the mean difference in the Scar characteristics including Scar assessment scores, scar thickness among others. Data synthesis: Descriptive data synthesis and mean differences between treatment arms will be calculated for the primary outcome of the scar assessment scores. In case more than three studies provide consistent characteristics of the scar assessment scores, a meta-analysis will be conducted. Discussion: Evidence obtained from the systematic review will form the foundation upon which further clinical trials research will be conducted in evaluating the efficacy of autologous adipose-derived stromal vascular fraction in keloid and hypertrophic scar. The systematic review has been submitted to the PROSPERO database and is currently under review.


  • Open Access

    An Early Warning Mobile Health Screening and Risk Scoring App for Preventing In-Hospital Transmission of COVID-19 by Health Care Workers: Development and Feasibility Study

    by Ronald Mbiine, Cephas Nakanwagi, Herve Monka Lekuya, Joan Aine, Kawesi Hakim, Lilian Nabunya, Henry Tomusange

    Background: Hospitals have been identified as very high-risk places for COVID-19 transmission between health care workers and patients who do not have COVID-19. Health care workers are the most at-risk population to contract and transmit the infection, especially to already vulnerable patients who do not have COVID-19. In low-income countries, routine testing is not feasible due to the high cost of testing; therefore, presenting the risk of uncontrolled transmission within non-COVID-19 treatment wards. This challenge necessitated the development of an affordable intermediary screening tool that would enable early identification of potentially infected health care workers and for early real time DNA-polymerase chain reaction testing prioritization. This would limit the contact time of potentially infected health care workers with the patients but also enable efficient use of the limited testing kits. Objective: The aims of this study are to describe an early warning in-hospital mobile risk analysis app for screening COVID-19 and to determine the feasibility and user-friendliness of the app among health care workers. Methods: The primary result of this research project was the development of a mobile-based daily early warning system for in-hospital transmission of COVID-19. Overall, the Early Warning System for In-Hospital Transmission of COVID-19 (EWAS) mobile app was found to be feasible, with over 69% of the health care workers having logged more than 67% of the required times. Over 93% of the participants reported that the tool was easy to use. Results: The primary result of this research project was the development of a mobile-based daily early warning system for in-hospital transmission of COVID-19. Overall, the Early Warning System for In-Hospital Transmission of COVID-19 (EWAS) mobile app was found to be feasible, with 69% of the health care workers (69/100) having logged more than 67% of the required times. Of the 100 participants, 93 reported that the tool was easy to use. Conclusions: The EWAS mobile app is a feasible and user-friendly daily risk scoring tool for preventing in-hospital transmission of COVID-19. Although it was not designed to be a diagnostic tool but rather a screening tool, there is a need to evaluate its sensitivity in predicting persons likely to have contracted COVID-19.


  • Open Access

    Safety and Feasibility of Autologous Adipose-derived Stromal Vascular Fraction in the Treatment of Keloids: a Phase One Randomised Controlled Pilot Trial

    by Ronald Mbiine, Anthony Kayiira, Misaki Wayengera, Ian Munabi, Noah Kiwanuka, Rose Alenyo, Edris Wamala Kalanzi, Haruna Muwonge, Cephas Nakanwagi, Moses Joloba, et al.

    Autologous adipose-derived stromal vascular fraction (SVF) is described as a therapeutic alternative in keloid treatment. However, most conclusions are based on observational with the majority conducted in high-income countries and yet the highest-burden of keloids is in Low-and middle-income countries (LMICs). In order to explore the therapeutic benefits of SVF in keloids, the safety and feasibility of their use in LMICs need to be evaluated.Methods: In this phase 1 randomized controlled pilot clinical trial conducted in the Plastic Surgery Unit of Kirruddu National Referral Hospital Kampala, 8 patients were assigned 1:1 ratio into either SVF or Triamcinolone Acetonide (TAC) arms. In the SVF arm, a median (IQR) number of stromal cell infiltration of 2.7x106 (11x106) was administered while the controls received 10mg/ml TAC in a ratio of 1:1 TAC into keloid volume. Primary end-points were adverse events development based on the Common Terminology Criteria for Adverse Events (CTCAE) v5.0 tool and Feasibility assessment based on ≥70% recruitment feasibility and ≥80% interventional feasibility rates. Results: Participant mean age was 27.9 (±6.5) years with a female predilection of 5(63%). Overall, no adverse events were reported in the SVF arm while an ulceration in a single patient in the TAC arm which was a grade II adverse event was reported. Recruitment feasibility of 80% as well as interventional feasibility with 100% completion were reported. Conclusion: Based on our findings, autologous adipose-derived stromal vascular fraction is feasible and safe for the treatment of keloids. Trial registration: ClinicalTrials.gov, NCT04553159. Registered 17th September 2020. Link: https://clinicaltrials.gov/ct2/show/NCT04553159

  • Open Access

    High rates of gastroesophageal cancers in patients with dyspepsia undergoing upper gastrointestinal endoscopy in Uganda

    by Ronald Mbiine, Cephas Nakanwagi, Olivia Kituuka

    Background and study aims Dyspepsia is the most common presenting symptom in the gastrointestinal clinic of Mulago National Referral hospital. The etiology is essentially not fully described in our patient population. This study was therefore conducted to establish the causes of dyspepsia based on endoscopic diagnosis among patients with dyspepsia seeking care at the National Referral hospital of Uganda.Patients and methods This retrospective study conducted in the endoscopy unit of Mulago hospital reviewed 356 patient endoscopy reports spanning January 2018 to July 2020 with a focus on those with a referral indication of dyspepsia. Age and sex were the independent variables of interest while the endoscopy findings as reported by the endoscopist were the outcome variable of interest.Results Of the 356 endoscopy reports reviewed, 159 met the inclusion criterion of dyspepsia as the indication. Participant mean age was 47.7 years (± 16.53) with the majority (25.79 %) in the fifth decade while the male to female ratio was 1. The majority of patients had organic dyspepsia (90.57 %) while the commonest finding was gastritis 69 (43.4 %). Gastroesophageal cancers represented (18) 11.32 % of all findings. There was a positive association between age > 50 years with gastroesophageal cancers (7.639) as well as age < 50 years and functional dyspepsia (2.794); however, all these were not statistically significant (P = 0.006 and (P = 0.095, respectively).Conclusions Organic/structural dyspepsia comprises over 90 % of investigated dyspepsia with 11 % comprising cancer among patients seeking endoscopy at the National Referral Hospital of Uganda.